Fitzsimons Innovation Community
Fitzsimon_menu

Find out what's happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

Blog
Fitzsimons Innovation Community Congratulates CEO Steve VanNurden on His Retirement
December 2, 2024
News
Fitzsimons Innovation Community CEO Announces Retirement
December 2, 2024
News
Fitzsimons Innovation Community Selected as New Home for RefinedScience
November 12, 2024
Fitzsimons Innovation Community Congratulates CEO Steve VanNurden on His Retirement
Blog | Dec 02, 2024

Fitzsimons Innovation Community Congratulates CEO Steve VanNurden on His Retirement

After almost 35 years in the life sciences industry, Steve VanNurden, President and CEO of Fitzsimons Innovation Community is announcing his retirement. A successful, decades-long career is bound to be filled with milestones, accomplishments, and accolades, and of course this is true for VanNurden, but to him, it all boils down to one thing: patient care.

Fitzsimons Innovation Community CEO Announces Retirement
News | Dec 02, 2024

Fitzsimons Innovation Community CEO Announces Retirement

Fitzsimons Innovation Community President and CEO Steve VanNurden will retire at the end of 2024. After nearly 35 years as a life sciences industry leader, VanNurden leaves a lasting impact on the Community, on the adjacent University of Colorado (CU) Anschutz Medical Campus where he also serves as Associate Vice Chancellor of Biotechnology, and on Colorado’s life sciences ecosystem.

Fitzsimons Innovation Community Selected as New Home for RefinedScience
News | Nov 12, 2024

Fitzsimons Innovation Community Selected as New Home for RefinedScience

Fitzsimons Innovation Community, an integrated campus of leading-edge facilities for innovative health and life sciences companies, announces RefinedScience, a Colorado high-tech biosciences company working to transform precision drug development, has selected the Community for its Colorado headquarters. To accelerate its path to market, RefinedScience will transition from The Foundry, a CU Innovations incubator housed in Bioscience 1, to permanent lab and office space in Bioscience 3 at Fitzsimons Innovation Community.

RefinedScience: A Homegrown Success Story Finds a New Home at Fitzsimons Innovation Community
Blog | Nov 12, 2024

RefinedScience: A Homegrown Success Story Finds a New Home at Fitzsimons Innovation Community

At Fitzsimons Innovation Community, we get extremely excited when new organizations put down roots on our campus. But sometimes, these new Community members aren’t really new at all. We can explain. A couple months ago here on the blog, we talked about CU Innovations, and how it provides a path to commercialization for the breakthrough work coming out of the University of Colorado Anschutz Medical Campus. In essence, it’s a way for new discoveries happening through the course of research and training to evolve into new organizations and make their way to market. RefinedScience, a high-tech biosciences company that uses unique access to and analysis of specialized data to inform drug development and discovery, is the newest Community member on the Fitzsimons campus and a perfect example of a CU Innovations success story.

Change Please Brings Coffee with a Cause to Fitzsimons Innovation Community
Blog | Oct 31, 2024

Change Please Brings Coffee with a Cause to Fitzsimons Innovation Community

Here on the Fitzsimons Innovation Community campus, life sciences professionals thrive on collaboration, innovation, and breakthroughs in patient care. Another thing they thrive on? Caffeine. One of our newest Community members brings caffeine to spare, but they also bring compassion, forward thinking, and a business model that drives meaningful social change—one cup of coffee at a time.

Lohocla Research Corp. Recognized as 2024 Colorado Inno Award Winner
News | Oct 28, 2024

Lohocla Research Corp. Recognized as 2024 Colorado Inno Award Winner

Colorado Inno Awards has selected Lohocla Research Corp as one of its 10 trailblazers making waves in the Colorado innovation ecosystem. Lohocla received FDA clearance in March for the first-in-human trials of a drug, Nezavist, intended to treat alcohol use disorder and craving. The company also received similar FDA clearance in October 2023 to move forward with Phase 1 trials of another drug it developed, Kindolor, to treat chronic pain.

Aurora mayor eyes redevelopment as catalyst to city's success
News | Oct 28, 2024

Aurora mayor eyes redevelopment as catalyst to city's success

Mike Coffman, City of Aurora Mayor and Fitzsimons Innovation Community Board Member, gave his annual State of the City address last week with a focus on maximizing the opportunity that exists with ongoing development of the CU Anschutz Medical Campus and the Fitzsimons Innovation Community.

Steve VanNurden Joins Denver Dealmakers Hall of Fame
News | Oct 28, 2024

Steve VanNurden Joins Denver Dealmakers Hall of Fame

Steve VanNurden, Fitzsimons Innovation Community President and CEO, was inducted into the Denver Dealmakers Hall of Fame, recognizing a class of dealmakers that has made an often-groundbreaking impact on their organizations, industries, and the region over the course of decades in business.

Here's How Denver Stacks up at Landing Company Headquarters
News | Oct 28, 2024

Here's How Denver Stacks up at Landing Company Headquarters

Metro Denver EDC hosted national site selectors to learn about Colorado’s competitive advantage. Adams County was highlighted for its opportunity to gain companies by providing data that shows how it is a more affordable community directly adjacent to the city of Denver.

OncoVerity CEO Featured in Pharmaceutical Executive’s Profiles in Medicine Series
News | Oct 04, 2024

OncoVerity CEO Featured in Pharmaceutical Executive’s Profiles in Medicine Series

With over three decades in biotech, Max Colao, CEO of OncoVerity, is at the forefront of personalized cancer treatment. In this compelling interview with Pharmaceutical Executive, Colao discusses his journey from industry giants to leading the startup OncoVerity in revolutionizing oncology care through computational biology and machine learning.

ClinImmune, RheumaGen Innovator Brian Freed Receives ASHI’s Highest Honor
News | Oct 04, 2024

ClinImmune, RheumaGen Innovator Brian Freed Receives ASHI’s Highest Honor

Brian Freed, Ph.D., Co-Founder & Chief Science Officer, RheumaGen, Executive Director, ClinImmune, and Professor of Medicine, University of Colorado will be recognized by the American Society of Histocompatibility & Immunogenetics (ASHI) with their highest honor.

Strategic Life Sciences Partnerships Find a New Altitude
Blog | Sep 26, 2024

Strategic Life Sciences Partnerships Find a New Altitude

For the past 15 years, Elyse Blazevich has been innovating and creating new pathways in life sciences discovery in Colorado, most recently as President and CEO of the Colorado BioScience Association (CBSA) and President of the Colorado BioScience Institute. An important Fitzsimons Innovation Community partner from their beginning, CBSA advances Colorado’s life sciences ecosystem by building a collaborative, pro-innovation business environment. CBSA expands access to capital, offers education and networking opportunities for their members, and advocates for life sciences companies by creating strong partnerships with policymakers and business leaders. One of the many ways they provide these opportunities is through the Rocky Mountain Life Sciences Investor & Partnering Conference, an event Fitzsimons Innovation Community is always honored to sponsor.

Load More
© 2024

 Fitzsimons Innovation Community